During the past decade, Fundacao Pio XII conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 7 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacao Pio XII" #1 sponsor was "Janssen Research & Development, LLC" with 14 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Hospital Israelita Albert Einstein" with 3 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored and "Hospital Sirio-Libanes" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacao Pio XII" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "CytoDyn, Inc." with 2 trials as a collaborator, "Hospital do Coracao" with 2 trials as a collaborator, "Ache Laboratorios Farmaceuticos S.A." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Fundacao Pio XII" are "Breast Cancer" (2 trials), "COVID-19 Pneumonia" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Fundacao Pio XII" in a lesser frequency.

Most popular intervention types in "Fundacao Pio XII" are "Drug" (25 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Abemaciclib" (4 trials), "Amivantamab" (3 trials), "Carboplatin" (3 trials) and "Erdafitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Pio XII" are 21 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Fundacao Pio XII". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fundacao Pio XII, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Pio XII, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".